Cite
HARVARD Citation
Voorhees, P. et al. (n.d.). Long‐term outcomes for newly‐diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study. British journal of haematology. pp. 373-377. [Online].